Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.24.2.u1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2022
Cash flows from operating activities:      
Net income $ 2,761,896 $ 3,387,351 $ 3,322,060
Adjustments to reconcile net income to net cash provided by operating activities:      
Impairment of goodwill and purchased intangible assets 289,474 9,905 5,962
Depreciation and amortization 401,730 415,113 363,344
Loss on extinguishment of debt 0 13,286 0
Unrealized foreign exchange (gain) loss and other (12,533) (17,825) 46,531
Asset impairment charges 11,307 0 0
Disposal of non-controlling interest 0 8,270 0
Stock-based compensation expense 212,695 171,424 126,918
Gain on sale of business 0 (29,687) 0
Deferred income taxes (155,228) (298,145) (329,501)
Settlement of treasury lock agreement 415 0 82,799
Changes in assets and liabilities, net of assets acquired and liabilities assumed in business acquisitions:      
Accounts receivable (80,894) (48,534) (510,326)
Inventories (164,092) (749,047) (567,003)
Other assets (289,509) (121,018) (217,070)
Accounts payable 24,976 (144,661) 101,632
Deferred system revenue 334,136 150,750 213,368
Deferred service revenue 203,106 88,223 129,718
Other liabilities (228,904) 834,400 544,270
Net cash provided by operating activities 3,308,575 3,669,805 3,312,702
Cash flows from investing activities:      
Proceeds from sale of assets 5,079 0 27,658
Net proceeds from sale of business 0 75,358 0
Business acquisitions, net of cash acquired (3,682) (27,144) (479,113)
Capital expenditures (277,384) (341,591) (307,320)
Purchases of available-for-sale securities (2,756,987) (1,441,933) (987,660)
Proceeds from sale of available-for-sale securities 107,773 124,620 113,538
Proceeds from maturity of available-for-sale securities 1,459,864 1,134,182 760,548
Purchases of trading securities (134,098) (96,611) (121,254)
Proceeds from sale of trading securities 121,020 89,528 116,350
Proceeds from other investments 1,430 1,020 795
Net cash used in investing activities (1,476,985) (482,571) (876,458)
Cash flows from financing activities:      
Payment of debt issuance costs 0 (6,515) 0
Proceeds from issuance of debt, net of issuance costs 735,043 0 2,967,409
Proceeds from revolving credit facility, net of costs 0 300,000 875,000
Repayment of debt 0 (1,087,250) (620,000)
Common stock repurchases (1,735,746) (1,311,864) (3,967,806)
Forward contract for accelerated share repurchases 0 0 (900,000)
Payment of dividends to stockholders (773,041) (732,556) (638,528)
Payment of dividends to subsidiary’s non-controlling interest holders 0 0 (602)
Issuance of common stock 144,934 124,847 113,014
Tax withholding payments related to vested and released restricted stock units (143,024) (94,806) (84,371)
Contingent consideration payable and other, net (4,183) (17,850) (1,121)
Purchase of non-controlling interest 0 (4,295) 0
Net cash used in financing activities (1,776,017) (2,830,289) (2,257,005)
Effect of exchange rate changes on cash and cash equivalents (6,309) (13,988) (28,941)
Net increase in cash and cash equivalents 49,264 342,957 150,298
Cash and cash equivalents at beginning of period 1,927,865 1,584,908 1,434,610
Cash and cash equivalents at end of period 1,977,129 1,927,865 1,584,908
Supplemental cash flow disclosures:      
Income taxes paid, net 830,835 495,101 464,526
Interest paid 276,597 223,955 154,673
Non-cash activities:      
Contingent consideration payable - financing activities (765) (1,878) 16,281
Dividends payable - financing activities 8,043 7,903 7,028
Unsettled common stock repurchase - financing activities 5,500 11,000 0
Accrued purchase of land, property and equipment - investing activities $ 13,849 $ 18,445 $ 19,595